Professor Wu focuses on the development of new chemical drugs from anti-aging Chinese medicine as the main axis, and established AcaHealth Pharma. & Biotech. Company in 2009 in Incubation Center of National Yang-Ming University, then built up with three standard plant in Wu-gu Industrial Park, New Taipei City. After the EH-201 isolated from anti-aging herb, it was approved by the US FDA and TFDA INDand has completed six single-dose phase I clinical trial in the hospital affiliated to Taipei Medical University., and it was safe and secure by
DSMB. The company has EH-201 global patents portfolio in indications including heart failure, anemia, chronic renal failure, dry eye, etc., and has also developed a global patent portfolio for EH-201 derivatives.